Documented in an LDA filing dated Jul 17, 2020
Sourced institutional rolesLDA lobbying records
JOSEPH RUBIN
JOSEPH RUBIN appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Prior government service disclosed in an LDA filing; exact dates not reported
Counsel and Legislative Director, Rep. George Gekas; Counsel, Rep. Steve Chabot
Federal government
Inspect source ↗Federal LDA filings
Lobbying Activity
CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2020
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages
LDA filing ↗CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2020
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2019
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2020
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021
LDA filing ↗CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2021
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021
LDA filing ↗CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2020
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages
LDA filing ↗CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2019
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2019
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗